skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Crystal structure of the adenosine A2A receptor bound to an antagonist reveals a potential allosteric pocket

Journal Article · · Proceedings of the National Academy of Sciences of the United States of America
 [1];  [1];  [1];  [2];  [3];  [2];  [2];  [2];  [1];  [4]
  1. ConfometRx, Inc., Santa Clara, CA (United States)
  2. UCB Pharma, Braine-l’Alleud (Belgium)
  3. UCB Pharma, Slough (United Kingdom)
  4. ConfometRx, Inc., Santa Clara, CA (United States); Stanford Univ. School of Medicine, CA (United States)

The adenosine A2Areceptor (A2AR) has long been implicated in cardiovascular disorders. As more selective A2AR ligands are being identified, its roles in other disorders, such as Parkinson’s disease, are starting to emerge, and A2AR antagonists are important drug candidates for nondopaminergic anti-Parkinson treatment. Here we report the crystal structure of A2Areceptor bound to compound 1 (Cmpd-1), a novel A2AR/N-methyld-aspartate receptor subtype 2B (NR2B) dual antagonist and potential anti-Parkinson candidate compound, at 3.5 Å resolution. The A2Areceptor with a cytochrome b562-RIL (BRIL) fusion (A2AR–BRIL) in the intracellular loop 3 (ICL3) was crystallized in detergent micelles using vapor-phase diffusion. Whereas A2AR–BRIL bound to the antagonist ZM241385 has previously been crystallized in lipidic cubic phase (LCP), structural differences in the Cmpd-1–bound A2AR–BRIL prevented formation of the lattice observed with the ZM241385–bound receptor. The crystals grew with a type II crystal lattice in contrast to the typical type I packing seen from membrane protein structures crystallized in LCP. Cmpd-1 binds in a position that overlaps with the native ligand adenosine, but its methoxyphenyl group extends to an exosite not previously observed in other A2AR structures. Structural analysis revealed that Cmpd-1 binding results in the unique conformations of two tyrosine residues, Tyr91.35and Tyr2717.36, which are critical for the formation of the exosite. As a result, the structure reveals insights into antagonist binding that are not observed in other A2AR structures, highlighting flexibility in the binding pocket that may facilitate the development of A2AR-selective compounds for the treatment of Parkinson’s disease.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
USDOE
OSTI ID:
1347032
Journal Information:
Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Issue 8; ISSN 0027-8424
Publisher:
National Academy of SciencesCopyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 88 works
Citation information provided by
Web of Science

References (34)

[19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors book January 1995
Refinement of Macromolecular Structures by the Maximum-Likelihood Method journal May 1997
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation journal May 2011
Adenosine A 2A Receptor Antagonists and Parkinson’s Disease journal July 2011
Anti-Inflammatory and Immunosuppressive Effects of the A 2A Adenosine Receptor journal January 2011
Exploring the gas access routes in a [NiFeSe] hydrogenase using crystals pressurized with krypton and oxygen journal August 2020
Fusion Partner Toolchest for the Stabilization and Crystallization of G Protein-Coupled Receptors journal June 2012
Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions journal July 2012
Crystallizing membrane proteins using lipidic mesophases journal April 2009
Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist journal November 2010
Potent antagonists for the human adenosine A2B receptor. Derivatives of the triazolotriazine adenosine receptor antagonist ZM241385 with high affinity journal November 1999
New therapies for the treatment of Parkinson's disease: Adenosine A2A receptor antagonists journal November 2005
Unprecedented Therapeutic Potential with a Combination of A2A/NR2B Receptor Antagonists as Observed in the 6-OHDA Lesioned Rat Model of Parkinson's Disease journal December 2014
Adenosine A 2A Receptor as a Drug Discovery Target journal November 2013
Discovery of 1,2,4-Triazine Derivatives as Adenosine A 2A Antagonists using Structure Based Drug Design journal January 2012
PARP1 exhibits enhanced association and catalytic efficiency with γH2A.X-nucleosome journal December 2019
A comprehensive review of the lipid cubic phase or in meso method for crystallizing membrane and soluble proteins and complexes journal January 2015
G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody journal January 2012
Modified T4 Lysozyme Fusion Proteins Facilitate G Protein-Coupled Receptor Crystallogenesis journal November 2014
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor journal August 2000
MolProbity : all-atom structure validation for macromolecular crystallography journal December 2009
Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine journal September 2011
Features and development of Coot journal March 2010
Adenosine A 2A receptor antagonist treatment of Parkinson’s disease journal August 2003
Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences journal July 2013
Structure of an Agonist-Bound Human A2A Adenosine Receptor journal March 2011
Molecular Determinants of CGS21680 Binding to the Human Adenosine A 2A Receptor journal March 2015
The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist journal November 2008
NMRPipe: A multidimensional spectral processing system based on UNIX pipes journal November 1995
Unprecedented therapeutic potential with a combination of A2A/NR2B receptor antagonists as observed in the 6-OHDA lesioned rat model of Parkinson's disease journal January 2016
Multi-functionality of a tryptophan residue conserved in substrate-binding groove of GH19 chitinases journal January 2021
Phaser crystallographic software journal July 2007
An Overview of Biological Macromolecule Crystallization journal May 2013
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997

Cited By (24)

Role of Extracellular Loops and Membrane Lipids for Ligand Recognition in the Neuronal Adenosine Receptor Type 2A: An Enhanced Sampling Simulation Study journal October 2018
The Role of Adenosine Receptors in Psychostimulant Addiction journal January 2018
Signaling within Allosteric Machines: Signal Transmission Pathways Inside G Protein-Coupled Receptors journal July 2017
Molecular Dynamics Simulations of the Allosteric Modulation of the Adenosine A2a Receptor by a Mini-G Protein journal April 2019
Ligand Modulation of Sidechain Dynamics in a Wild-Type Human GPCR journal February 2018
Pharmacology of Adenosine Receptors: The State of the Art journal July 2018
Toward G protein-coupled receptor structure-based drug design using X-ray lasers journal October 2019
The Aminotriazole Antagonist Cmpd‐1 Stabilises a Distinct Inactive State of the Adenosine 2A Receptor journal July 2019
New approaches towards the understanding of integral membrane proteins: A structural perspective on G protein-coupled receptors: Structural Perspective on G Protein-Coupled Receptors journal June 2017
Oligomeric Receptor Complexes and Their Allosteric Receptor-Receptor Interactions in the Plasma Membrane Represent a New Biological Principle for Integration of Signals in the CNS journal September 2019
Fast, Efficient, and Versatile Synthesis of 6-amino-5-carboxamidouracils as Precursors for 8-Substituted Xanthines journal February 2019
Could Adenosine Recognize its Receptors with a Stoichiometry Other than 1 : 1? journal April 2018
Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A 3 adenosine receptor antagonists journal January 2018
Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design book November 2017
Reconstruction of apo A2A receptor activation pathways reveal ligand-competent intermediates and state-dependent cholesterol hotspots journal October 2019
A 2A adenosine receptor functional states characterized by 19 F-NMR journal November 2018
Targeting adenosine A 2A receptor antagonism for treatment of cancer journal September 2018
The Aminotriazole Antagonist Cmpd‐1 Stabilises a Distinct Inactive State of the Adenosine 2A Receptor journal June 2019
3D-e-Chem: Structural Cheminformatics Workflows for Computer-Aided Drug Discovery journal February 2018
Metal Chelation Therapy and Parkinson’s Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs journal July 2019
A benchmark study of loop modeling methods applied to G protein-coupled receptors journal May 2019
Cryo-EM structure of the adenosine A 2A receptor coupled to an engineered heterotrimeric G protein posted_content February 2018
New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism: New paradigms in adenosine receptor pharmacology journal June 2018
Cryo-EM structure of the adenosine A2A receptor coupled to an engineered heterotrimeric G protein journal May 2018